Peter M. Hecht
2014 - Ironwood Pharmaceuticals
In 2014, Peter M. Hecht earned a total compensation of $2.3M as Chief Executive Officer at Ironwood Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Option Awards | $2,144,708 |
|---|---|
| Salary | $100,000 |
| Other | $7,421 |
| Total | $2,252,129 |
Hecht received $2.1M in option awards, accounting for 95% of the total pay in 2014.
Hecht also received $100K in salary and $7.4K in other compensation.
Rankings
In 2014, Peter M. Hecht's compensation ranked 4,044th out of 13,032 executives tracked by ExecPay. In other words, Hecht earned more than 69.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,044 out of 13,032 | 69th |
Division Manufacturing | 1,430 out of 4,966 | 71st |
Major group Chemicals And Allied Products | 464 out of 1,686 | 73rd |
Industry group Drugs | 359 out of 1,365 | 74th |
Industry Pharmaceutical Preparations | 287 out of 1,043 | 73rd |
Source: SEC filing on April 15, 2016.
Hecht's colleagues
We found five more compensation records of executives who worked with Peter M. Hecht at Ironwood Pharmaceuticals in 2014.
2014
Michael Higgins
Ironwood Pharmaceuticals
Chief Financial Officer
2014
Tom Graney
Ironwood Pharmaceuticals
Chief Financial Officer
2014
Mark Currie
Ironwood Pharmaceuticals
Chief Scientific Officer
2014
Thomas McCourt
Ironwood Pharmaceuticals
Senior Vice President, Marketing and Sales and Chief Commercial Officer
2014
Halley Gilbert
Ironwood Pharmaceuticals
Chief Legal Officer
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019